Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
- 15 June 2013
- journal article
- case report
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 190 (12), 6034-6042
- https://doi.org/10.4049/jimmunol.1202830
Abstract
Adoptive cell therapy with tumor-infiltrating lymphocytes (TILs) represents an effective treatment for patients with metastatic melanoma. However, most of the Ag targets recognized by effective melanoma-reactive TILs remain elusive. In this study, patient 2369 experienced a complete response, including regressions of bulky liver tumor masses, ongoing beyond 7 y following adoptive TIL transfer. The screening of a cDNA library generated from the autologous melanoma cell line resulted in the isolation of a mutated protein phosphatase 1, regulatory (inhibitor) subunit 3B (PPP1R3B) gene product. The mutated PPP1R3B peptide represents the immunodominant epitope recognized by tumor-reactive T cells in TIL 2369. Five years following adoptive transfer, peripheral blood T lymphocytes obtained from patient 2369 recognized the mutated PPP1R3B epitope. These results demonstrate that adoptive T cell therapy targeting a tumor-specific Ag can mediate long-term survival for a patient with metastatic melanoma. This study also provides an impetus to develop personalized immunotherapy targeting tumor-specific, mutated Ags.Keywords
This publication has 39 references indexed in Scilit:
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Melanoma genome sequencing reveals frequent PREX2 mutationsNature, 2012
- Expression of tumour-specific antigens underlies cancer immunoeditingNature, 2012
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patientsJCI Insight, 2011
- Exome sequencing identifies GRIN2A as frequently mutated in melanomaNature Genetics, 2011
- Diversity in T Cell Memory: An Embarrassment of RichesImmunity, 2009
- Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impairedBlood, 2009
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenBlood, 2009
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002